Cancer Letters
Volume 225, Issue 1 , Pages 1-26 , 8 July 2005

c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention

  • James G. Christensen

      Affiliations

    • Research Pharmacology, Pfizer Inc., La Jolla, CA 92121, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 858 638 6336; fax: +1 858 526 4275.
    • ,
  • Jon Burrows

      Affiliations

    • Rigel Inc. Pharmacology Department, South San Francisco, CA 94080, USA
    • ,
  • Ravi Salgia

      Affiliations

    • Section of Hematology/Oncology, Department of Medicine, The University of Chicago Medical Center, Pritzker School of Medicine, Chicago, IL 60637, USA

Received 20 September 2004 ,Accepted 29 September 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0304-3835(04)00765-7

doi: 10.1016/j.canlet.2004.09.044

Cancer Letters
Volume 225, Issue 1 , Pages 1-26 , 8 July 2005

Article Tools

* Image Usage & Resolution